Intra-abdominal Adiposity, Inflammation, and Cardiovascular Risk: New Insight into Global Cardiometabolic Risk

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2008 Mar 28

PMID 18367024

Citations 39

Authors

Paolo Calabro

Edward T H Yeh

Affiliations

Soon will be listed here.

Abstract

Increasing evidence supports the role of adipose tissue in the development of a systemic inflammatory state, which contributes to obesity-associated vasculopathy and cardiovascular risk. In addition to storing calories as triglycerides, adipocytes secrete a large variety of proteins, including cytokines, chemokines, and -hormone-like factors (eg, leptin, adiponectin, resistin). This production of pro chemokines by adipose tissue is of particular interest, because their local secretion by perivascular adipose depots may provide a new mechanistic link between obesity and its associated vascular complications. Insulin resistance, in subjects with or without diabetes, is frequently associated with obesity, particularly with an excess of intra-abdominal fat. Recently, the endocannabinoid system, among others, has been shown to be involved in the pathophysiology of visceral obesity and global cardiometabolic risk, as represented by the overall risk of developing type 2 diabetes or cardiovascular diseases.

Citing Articles

Long-term impact of adherence to muscle-strengthening guidelines on inflammation markers: a 17-year follow-up study with obesity parameters as mediators.

Garcia-Hermoso A, Ezzatvar Y, Yanez-Sepulveda R, Olivares-Arancibia J, Paez-Herrera J, Lopez-Gil J BMJ Open Sport Exerc Med. 2024; 10(4):e002229.

PMID: 39659710 PMC: 11628982. DOI: 10.1136/bmjsem-2024-002229.

Ginsenoside Rb in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms.

Song Y, Chen C, Li W Chin Herb Med. 2024; 16(4):489-504.

PMID: 39606264 PMC: 11589305. DOI: 10.1016/j.chmed.2024.09.006.

Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions.

Martemucci G, Khalil M, Di Luca A, Abdallah H, DAlessandro A Metabolites. 2024; 14(6).

PMID: 38921462 PMC: 11206163. DOI: 10.3390/metabo14060327.

Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial.

Nowak K, Moretti F, Bussola N, Steele C, Gregory A, Kline T Am J Kidney Dis. 2024; 84(3):275-285.e1.

PMID: 38608748 PMC: 11344693. DOI: 10.1053/j.ajkd.2024.02.014.

Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review.

Sandoval C, Nahuelqueo K, Mella L, Recabarren B, Souza-Mello V, Farias J Front Nutr. 2023; 10:1288804.

PMID: 38024342 PMC: 10665854. DOI: 10.3389/fnut.2023.1288804.

References

Calabro P, Samudio I, Safe S, Willerson J, Yeh E . Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. J Vasc Res. 2005; 42(6):509-16. DOI: 10.1159/000088260. View

Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez J, Gutierrez C . Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004; 12(6):962-71. DOI: 10.1038/oby.2004.118. View

Haffner S, Greenberg A, Weston W, Chen H, Williams K, Freed M . Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 2002; 106(6):679-84. DOI: 10.1161/01.cir.0000025403.20953.23. View

Ridker P, Rifai N, Stampfer M, Hennekens C . Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101(15):1767-72. DOI: 10.1161/01.cir.101.15.1767. View

Kern P, Ranganathan S, Li C, Wood L, Ranganathan G . Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001; 280(5):E745-51. DOI: 10.1152/ajpendo.2001.280.5.E745. View

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

Trayhurn P, Wood I . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92(3):347-55. DOI: 10.1079/bjn20041213. View

Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003; 289(14):1799-804. DOI: 10.1001/jama.289.14.1799. View

Ridker P, Hennekens C, Buring J, Rifai N . C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12):836-43. DOI: 10.1056/NEJM200003233421202. View

10.

Pagotto U, Pasquali R . Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. Lancet. 2005; 365(9468):1363-4. DOI: 10.1016/S0140-6736(05)66348-9. View

11.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

12.

Halaas J, Gajiwala K, Maffei M, Cohen S, Chait B, Rabinowitz D . Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269(5223):543-6. DOI: 10.1126/science.7624777. View

13.

Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M . Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003; 107(5):671-4. DOI: 10.1161/01.cir.0000055188.83694.b3. View

14.

Yudkin J . Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2004; 27 Suppl 3:S25-8. DOI: 10.1038/sj.ijo.0802496. View

15.

Rennie K, Jebb S . Prevalence of obesity in Great Britain. Obes Rev. 2005; 6(1):11-2. DOI: 10.1111/j.1467-789X.2005.00164.x. View

16.

Brekke H, Lenner R, Taskinen M, Mansson J, Funahashi T, Matsuzawa Y . Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Res Clin Pract. 2005; 68(1):18-28. DOI: 10.1016/j.diabres.2004.07.023. View

17.

Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112(12):1821-30. PMC: 296998. DOI: 10.1172/JCI19451. View

18.

Ahima R, Flier J . Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000; 11(8):327-32. DOI: 10.1016/s1043-2760(00)00301-5. View

19.

Weyer C, Yudkin J, Stehouwer C, Schalkwijk C, Pratley R, Tataranni P . Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis. 2002; 161(1):233-42. DOI: 10.1016/s0021-9150(01)00626-8. View

20.

Lee J, Bullen Jr J, Stoyneva V, Mantzoros C . Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am J Physiol Endocrinol Metab. 2004; 288(3):E625-32. DOI: 10.1152/ajpendo.00184.2004. View